NASDAQ Equity Snapshot

CGON Weekly Equity Report

CG Oncology, Inc. Common stock

Interactive chart JSON snapshot
Latest Close 59.56 USD 12 Jun 2026
1W Return 10.9% latest completed week
4W Return -11.0% short-term follow-through
12W Return -8.5% quarterly tape
Trend Breadth 80.8% 42 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing pioneering cancer therapies, particularly through its lead product, CG0070, an oncolytic virus therapy designed for non-muscle invasive bladder cancer. Committed to addressing significant unmet medical needs in the oncology space, the company is well-positioned to enhance patient outcomes and transform existing treatment paradigms. As CG Oncology progresses through clinical trials and regulatory processes, its proprietary technology platform sets it apart in the competitive oncology landscape, presenting compelling investment opportunities for institutional investors keen on advancing innovations that may substantially influence cancer care.

Snapshot

What the weekly tape is saying

CGON closed the latest completed week at 59.56 USD. The 4-week return is -11.0% and the 12-week return is -8.5%. Trend Signal is active, Market Dynamics is -0.97. Setup signature: Balanced read with a 43/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 5.0%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 89 Persistence of active Trend Signal over the last year and current streak.
Momentum 17 Blend of 4-week and 12-week follow-through.
Dynamics 12 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 73 Relative leadership and short-term RS change.
Volume 36 Participation compared with the 13-week volume baseline.
Risk Control 28 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
56.70 USD
Vs Trend Line
5.0%
Fair Value
38.52 USD
Vs Fair Value
54.6%
52W High
75.50 USD
52W Low
23.65 USD
Drawdown
-21.1%
Range Position
69.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 10.9%
4W -11.0%
12W -8.5%
26W 45.5%
52W 130.3%

Trend read

Active Streak
42 weeks
52W Active Weeks
42
52W Active Breadth
80.8%
Sector Scope
US Healthcare
Sector Rank
94 of 1033
Sector Percentile
91.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.97
4W MD Change
-260.3%
Relative Strength
9.40
4W RS Change
-68.1%
Expectation
Positive
Probability
55.68%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
4.6M
13W Average
5.4M
52W Average
5.0M
Vs 13W
0.9x
Vs 52W
0.9x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.3%
52W Volatility
7.0%
Upside Weeks
31
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
5.7% / -3.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
5.5B

Opportunity signals

  • Trend Signal is active with a 42-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 59.56 USD 10.9% 56.70 USD 38.52 USD -0.97 9.40 4.6M On
5 Jun 2026 53.72 USD -13.8% 56.08 USD 38.35 USD -0.67 1.81 4.6M On
29 May 2026 62.29 USD -3.1% 55.62 USD 38.22 USD -0.20 13.47 4.6M On
22 May 2026 64.25 USD -4.0% 54.98 USD 38.03 USD 0.18 21.52 4.2M On
15 May 2026 66.93 USD -3.9% 54.30 USD 37.81 USD 0.61 29.46 5.6M On
8 May 2026 69.62 USD 5.1% 53.45 USD 37.56 USD 0.97 35.86 3.8M On
1 May 2026 66.27 USD -3.5% 52.57 USD 37.29 USD 1.20 38.24 3.5M On
24 Apr 2026 68.68 USD -6.5% 51.69 USD 37.04 USD 1.46 47.02 4.4M On
17 Apr 2026 73.43 USD 8.5% 50.65 USD 36.77 USD 1.56 63.32 7.1M On
10 Apr 2026 67.70 USD 0.3% 49.43 USD 36.45 USD 1.61 62.89 6.2M On
2 Apr 2026 67.48 USD 4.4% 48.28 USD 36.18 USD 1.65 72.93 5.3M On
27 Mar 2026 64.62 USD -0.7% 47.14 USD 35.90 USD 1.63 75.98 5.3M On
20 Mar 2026 65.08 USD 1.2% 45.88 USD 35.64 USD 1.55 74.51 10.4M On
13 Mar 2026 64.29 USD 3.9% 44.61 USD 35.38 USD 1.32 71.85 11.2M On